1-8 of 8
addison's disease
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autoimmune-Associated Human Leukocyte Antigen (HLA) Alleles As Risk Factors for Heparin-Induced Thrombocytopenia (HIT) Antibodies

Ray Zhang, MD PhD, Brian Duffy, MA, Vinzenz Lange, PhD, Charles S. Eby, MD, Chang Liu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3737.
https://doi.org/10.1182/blood-2018-99-120074
Published: 2018
Journal Articles

A Phase 1 Study of Nivolumab in Combination with Ipilimumab for Relapsed or Refractory Hematologic Malignancies (CheckMate 039)

Stephen Ansell, MD PhD, Martin E Gutierrez, MD, Margaret A. Shipp, MD, Douglas Gladstone, MD, Alison Moskowitz, Ivan Borello, Mihaela Popa-Mckiver, Benedetto Farsaci, Lili Zhu, MS, Alexander M. Lesokhin, MD, Philippe Armand, MD PhD
Journal: Blood
Blood (2016) 128 (22): 183.
https://doi.org/10.1182/blood.V128.22.183.183
Published: 2016
Journal Articles

Patient Subgroup Analysis of Quality-of-Life Outcomes in Checkmate 205, a Phase 2 Study of Nivolumab in Patients with Classical Hodgkin Lymphoma

Andreas Engert, MD, Fiona Taylor, Bryan Bennett, Ishan Hirji, Kim Cocks, Jeffrey McDonald, Erin Mann, Kazunobu Kato, MD, David Cella, PhD
Journal: Blood
Blood (2016) 128 (22): 1831.
https://doi.org/10.1182/blood.V128.22.1831.1831
Published: 2016
Journal Articles

Elotuzumab Plus Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: 2-Year Follow-up

Antonio Palumbo, MD, Massimo Offidani, MD, Brigitte Pégourie, Javier De La Rubia, Laurent Garderet, MD, Kamel Laribi, Alberto Bosi, MD, Roberto Marasca, MD, Jacob P. Laubach, MD, Ann Mohrbacher, MD, Angelo Michele Carella, MD, Anil K. Singhal, Mark Lynch, Ying-Ming Jou, Andrzej Jakubowiak, MD PhD
Journal: Blood
Blood (2015) 126 (23): 510.
https://doi.org/10.1182/blood.V126.23.510.510
Published: 2015
Journal Articles

Eloquent-2 Update: A Phase 3, Randomized, Open-Label Study of Elotuzumab in Combination with Lenalidomide/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma - 3-Year Safety and Efficacy Follow-up

Meletios A. Dimopoulos, Sagar Lonial, MD, Darrell White, MD, Philippe Moreau, Antonio Palumbo, MD, Jesus San Miguel, MDPhD, Ofer Shpilberg, MD MPH, Kenneth C. Anderson, MD, Sebastian Grosicki, MD PhD, Ivan Spicka, MD PhD, Adam Walter-Croneck, Hila Magen-Nativ, Maria-Victoria Mateos, Andrew Belch, Donna Reece, Meral Beksac, MD, Eric Bleickhardt, Valerie Poulart, Jessica Katz, Anil K. Singhal, Paul G. Richardson
Journal: Blood
Blood (2015) 126 (23): 28.
https://doi.org/10.1182/blood.V126.23.28.28
Published: 2015
Journal Articles

Induction Therapy for Gamma-Heavy Chain Disease with Bortezomib and Dexamethasone: A Case Report

Jon E. Arnason, MD, Lourdes M. Mendez, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 5051.
https://doi.org/10.1182/blood.V120.21.5051.5051
Published: 2012
Journal Articles

What Predicts Adrenal Insufficiency in Patients with Thalassemia Major?

Karen E Huang, MD, Steven D Mittelman, MD, PhD, Thomas D. Coates, MD, Mitchell Geffner, MD, John C Wood, MD, Ph.D
Journal: Blood
Blood (2011) 118 (21): 5299.
https://doi.org/10.1182/blood.V118.21.5299.5299
Published: 2011
Journal Articles

Adrenal Insufficiency: A Common Finding in Adults with Sickle Cell Disease (SCD)

Lawrence R. Solomon, MD
Journal: Blood
Blood (2008) 112 (11): 4802.
https://doi.org/10.1182/blood.V112.11.4802.4802
Published: 2008